On November 13, 2023, the Alliance for a Stronger FDA hosted a webinar with James "Jim" Jones, the recently appointed Deputy Commissioner for Human Foods at the U.S. Food and Drug Administration (FDA), during which he discussed his priorities, plans, and approach to change at the agency.
The nonprofit Reagan-Udall Foundation that advises the FDA is recommending the agency lead an inter-agency and industry task force to streamline and strengthen post-approval studies of drugs and devices.
An Alliance for a Stronger FDA webinar on Monday, Nov. 13, will feature Jim Jones, FDA Deputy Commissioner for Human Foods. Alison Bodor of the American Frozen Foods Institute, and Thomas Gremillion of the Consumer Federation of America, will moderate.
When bacteria develop resistance to front-line antibiotics, health care professionals lose their ability to treat deadly infections, leading to more than 35,000 deaths annually in the U.S. and more than 1.2 million worldwide.
How can FDA and other stakeholders better facilitate and support post-market pragmatic evidence generation studies – studies that answer clinically meaningful questions and address gaps in clinical evidence that directly impact how care is managed in the United States?
